Researcher
Linda De Meirleir
- Keywords:Medicine
Affiliations
- Pediatrics (Department)
Member
From1 Feb 2016 → 15 Oct 2018 - Clinical sciences (Department)
Member
From1 Jan 2014 → 31 Oct 2018 - Neurogenetics (Research group)
Responsible
From29 Jun 2011 → 31 Oct 2018 - Reproduction and Genetics (Research group)
Member
From21 Jun 2010 → 31 Oct 2018 - Pediatrics (Department)
Member
From1 Jan 2008 → 31 Oct 2018 - Pediatrics (Department)
Member
From1 Feb 1997 → 31 Dec 2013
Projects
1 - 1 of 1
- Development of diagnostic, biochemical and molecular methods, the prevention and the study of treatment of OXPHOS deficiency.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 63
- Parenteral hydroxocobalamin dose intensification in five patients with different types of early onset intracellular cobalamin defects(2019)
Authors: Emmanuel Scalais, Elise Osterheld, Christine Geron, Charlotte Pierron, Ronit Chafai, Vincent Schlesser, Patricia Borde, Luc Régal, Hilde Laeremans, Koen L I van Gassen, et al.
Pages: 70-79 - Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial(2019)
Authors: Stefan Groeneweg, Robin P. Peeters, Carla Moran, Mb Athanasia Stoupa, Francoise Auriol, Davide Tonduti, Alice Dica, Laura Paone, Klara Rozenkova, Jana Malikova, et al.
Pages: 695-706 - Research activity and capability in the European reference network MetabERN(2019)
Authors: Jean-Michel Heard, Cinzia Bellettato, Corine van Lingen, Francois-Guillaume Debray, Marie-Cecile Nassogne, Rudy Van Coster, Linda De Meirleir, Francois Eyskens, Eva Morava, Ivo Baric, et al.
Pages: 119 - Multidisciplinary diagnostic settings for children with a neurobiological developmental delay or disorder in Flanders: comparison of governmental regulations.(2019)Edition: S2Volume: 61
Authors: Linda De Meirleir
Pages: 7-7Number of pages: 1 - Clinical implementation of gene panel testing for lysosomal storage diseases(2019)
Authors: Alexander Gheldof, Sara Seneca, Katrien Stouffs, Willy Lissens, Anna C Jansen, Hilde Laeremans, Patrick Verloo, An-Sofie Schoonjans, Marije Meuwissen, Diana Barca, et al.
- Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disordersA successful strategy for clinical research of rare diseases(2019)
Authors: Roland Posset, Sven F. Garbade, S P Nikolas Boy, Alberto B Burlina, Carlo Dionisi-Vici, Dries Dobbelaere, Angeles Garcia-Cazorla, Pascale De Lonlay, Elisa Leao Teles, Roshni Vara, et al.
Pages: 93-106 - Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis(2018)
Authors: Line Borgwardt, Nathalie Guffon, Yasmina Amraoui, Christine I. Dali, Linda De Meirleir, Mercedes Gil Campos, Bénédicte Heron, Silvia Geraci, Diego Ardigò, Federica Cattaneo, et al.
Pages: 1215-1223 - Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis(2018)
Authors: Allan Meldgaard Lund, Line Borgwardt, Federica Cattaneo, Diego Ardigò, Silvia Geraci, Mercedes Gil Campos, Linda De Meirleir, Cécile Laroche, Philippe Dolhem, Duncan Cole, et al.
Pages: 1225-1233 - International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome(2018)
Authors: Rossella Parini, Alexander Broomfield, Maureen Anne Cleary, Linda De Meirleir, Maja Di Rocco, Waseem Mahmoud Fathalla, Nathalie Guffon, Christina Lampe, Allan Meldgaard Lund, Maurizio Scarpa, et al.
Pages: 2059-2065 - Easy-to-use algorithm would provide faster diagnoses for mucopolysaccharidosis type I and enable patients to receive earlier treatment(2018)
Authors: Anna Tylki-Szymańska, Linda De Meirleir, Maja Di Rocco, Waseem M Fathalla, Nathalie Guffon, Christina Lampe, Allan Meldgaard Lund, Rossella Parini, Frits A Wijburg, Jiri Zeman, et al.
Pages: 1402-1408